NCT01856881View on ClinicalTrials.gov

Multiple Ascending Dose Study in Subjects With Type 2 Diabetes

PHASE1TerminatedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

March 31, 2015

Conditions
Diabetes Mellitus
Interventions
DRUG

AMG 876

Ascending multiple doses of study drug administered SC

Trial Locations (6)

33025

Research Site, Miramar

45255

Research Site, Cincinnati

66212

Research Site, Overland Park

78209

Research Site, San Antonio

91911

Research Site, Chula Vista

98057

Research Site, Renton

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT01856881 - Multiple Ascending Dose Study in Subjects With Type 2 Diabetes | Biotech Hunter | Biotech Hunter